We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+25.19%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.52B
AUM Growth
+$762M
Cap. Flow
+$251M
Cap. Flow %
5.54%
Top 10 Hldgs %
32.69%
Holding
126
New
33
Increased
18
Reduced
34
Closed
36

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$104M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$86M
3
AGN
Allergan plc
AGN
+$83.3M
4
PFE icon
Pfizer
PFE
+$80.2M
5
PBYI icon
Puma Biotechnology
PBYI
+$79.5M

Top Sells

Rank Stock Value
1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$145M
2
ABT icon
Abbott
ABT
+$82.8M
3
GDDY icon
GoDaddy
GDDY
+$79.9M
4
AERI
Aerie Pharmaceuticals
AERI
+$68.4M
5
BLK icon
Blackrock
BLK
+$65.5M

Sector Composition

Rank Sector Weight
1 Healthcare 54.61%
2 Technology 11.18%
3 Communication Services 3.96%
4 Consumer Discretionary 3.1%
5 Financials 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APTV icon
51
Aptiv
APTV
$12B
$31.1M 0.69%
+391,418
New +$30.1M
NFLX icon
52
Netflix
NFLX
$299B
$30.8M 0.68%
+864,200
New +$30M
EW icon
53
CALL
Edwards Lifesciences
EW
$49.6B
$29.9M 0.66%
+469,500
New +$26.8M
WMGI
54
DELISTED
Wright Medical Group Inc
WMGI
$28.6M 0.63%
910,190
-474,016
-34% -$14.4M
SAGE
55
DELISTED
Sage Therapeutics
SAGE
$27M 0.6%
169,676
-336,100
-66% -$48.7M
GOOGL icon
56
Alphabet (Google) Class A
GOOGL
$4.36T
$25.9M 0.57%
440,980
-880,840
-67% -$49.7M
DBX icon
57
Dropbox
DBX
$7.6B
$25.3M 0.56%
1,162,707
-359,490
-24% -$8.37M
QURE icon
58
uniQure
QURE
$3.03B
$24.9M 0.55%
+416,862
New +$18.6M
ONCE
59
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$24.6M 0.54%
215,821
-1,967,572
-90% -$145M
SE icon
60
Sea Limited
SE
$65.4B
$23.7M 0.52%
+1,007,969
New +$17.7M
FICO icon
61
Fair Isaac
FICO
$24.3B
$23.4M 0.52%
+86,256
New +$20.3M
A icon
62
Agilent Technologies
A
$39.1B
$22.6M 0.5%
+281,069
New +$21.3M
FATE icon
63
Fate Therapeutics
FATE
$286M
$22.5M 0.5%
1,281,536
-189,464
-13% -$2.99M
LAB icon
64
Standard BioTools
LAB
$340M
$19.2M 0.42%
+1,441,363
New +$15.2M
CSII
65
DELISTED
Cardiovascular Systems, Inc.
CSII
$17.3M 0.38%
446,921
-1,152,946
-72% -$39.1M
TCOM icon
66
Trip.com Group
TCOM
$29.6B
$16.6M 0.37%
+379,510
New +$13.3M
COUP
67
DELISTED
Coupa Software Incorporated
COUP
$16.5M 0.36%
180,922
-118,693
-40% -$10.2M
TWLO icon
68
Twilio
TWLO
$30B
$16.2M 0.36%
125,755
-27,086
-18% -$3.05M
DATA
69
DELISTED
Tableau Software, Inc.
DATA
$15.5M 0.34%
121,435
-188,021
-61% -$23.7M
CHRS icon
70
Coherus Oncology
CHRS
$217M
$12.9M 0.29%
+947,061
New +$12.6M
PVTL
71
DELISTED
Pivotal Software, Inc.
PVTL
$12.2M 0.27%
584,051
-640,758
-52% -$12.5M
EQ icon
72
Equillium
EQ
$139M
$11.6M 0.26%
1,446,972
+92,985
+7% +$766K
SPLK
73
DELISTED
Splunk Inc
SPLK
$11.2M 0.25%
+90,080
New +$11.2M
PCRX icon
74
Pacira BioSciences
PCRX
$1.04B
$10.7M 0.24%
282,197
-241,300
-46% -$9.42M
ALNA
75
DELISTED
Allena Pharmaceuticals
ALNA
$10.3M 0.23%
1,463,208
-304,896
-17% -$2.21M
1 2
3
4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q1 2019 Portfolio in Review

As of Q1 2019, PFM Health Sciences held 126 positions worth $4.52B, up 20% from $3.76B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

PFM Health Sciences deployed $251M of net new capital in Q1 2019, opening 33 new positions and adding to 18 existing holdings. Its largest new stake was Stryker: 579,444 shares worth $114M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 51% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Spark Therapeutics, Inc. Common Stock, an estimated $145M trimmed.

  • PFM Health Sciences's largest Q1 2019 buy was Stryker: 579,444 shares worth $114M.
  • PFM Health Sciences added most to Pfizer in Q1 2019, an estimated $80.2M increase.
  • PFM Health Sciences's biggest Q1 2019 reduction was Spark Therapeutics, Inc. Common Stock, cutting an estimated $145M.
  • PFM Health Sciences fully exited Abbott in Q1 2019, selling an estimated $82.8M.
  • PFM Health Sciences's ten largest holdings make up 33% of its $4.52B portfolio in Q1 2019.
  • PFM Health Sciences opened 33 new positions and closed 36 in Q1 2019.
  • PFM Health Sciences's portfolio value rose 20% quarter-over-quarter to $4.52B.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.